You are here

  • Home
  • Archive
  • Volume 30, Issue 1
  • Efficacy and safety of PD-1/PD-L1 plus CTLA-4 antibodies ± other therapies in lung cancer: a systematic review and meta-analysis

Article metrics

Article menu
Systematic review
Efficacy and safety of PD-1/PD-L1 plus CTLA-4 antibodies ± other therapies in lung cancer: a systematic review and meta-analysis

 

Online download statistics by month:

Online download statistics by month: September 2021 to August 2023

AbstractFullPdf
Sep 2021826806208
Oct 2021568567100
Nov 202129429261
Dec 202120721271
Jan 202224024040
Feb 202223223345
Mar 202223123136
Apr 202224424634
May 202221622251
Jun 202214814942
Jul 202214514219
Aug 202216216230
Sep 202216016241
Oct 202216116740
Nov 202213614127
Dec 202227627539
Jan 202339138969
Feb 202340641687
Mar 202326927171
Apr 202317617567
May 202317517866
Jun 202314214137
Jul 202321320975
Aug 202324324350
Total626162691406